科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background: A single dose of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) was shown to be immunogenic and well tolerated when given either as a booster to formalin-inactivated Japanese encephalitis (JE)-vaccine (mouse brain-derived vaccine [MBDV])-primed 2-5-year-olds, or as a primary vaccination to JE-vaccine-naive 12-24-month-old toddlers in Thailand. A 5-year follow-up assessment of immune response persistence over time was conducted. Methods: Four additional visits (at 2, 3, 4, and 5 years) for immunologic assessments were added to the original 12-month open-label crossover study, in which 100 healthy children aged 2-5 years with a history of two-dose primary vaccination with MBDV (according to the Thai Expanded Program for Immunization schedule), and 200 healthy JE-vaccine-naive 12-24-month-old toddlers, were randomized 1:1 to receive JE-CV, containing >= 4 log(10) plaque forming units, I month before or after hepatitis A control vaccine. Results: In MBDV-primed 2-5-year-olds (n = 78), the immune response to the JE-CV vaccine persisted up to at least 5 years after vaccination with a single dose of JE-CV, with all (n = 78) children seroprotected at the year 5 visit (geometric mean titers [GMT]: 252 1/dil). There was no decrease of seroprotection rate over time (100% at 6 months post-vaccination and 96.8% (90.3-98.9) at 5 years post-vaccination). In JE-vaccine-naive toddlers, a protective immune response persisted up to at least 5 years in 58.8% (50.9-66.4) after a single -dose administration of JE-CV (GMT 26.7 1/dil; sensitivity analysis). Conclusions: A single -dose of JE-CV as a booster following MBDV administration provided long-lasting immunity. In JE-vaccine-naive toddlers, despite relatively high seroprotection rates persisting over time, a subsequent booster dose is recommended following a JE-CV primary vaccination for long-term protection.
- 出版日期2016-11-4
